{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:45:39Z","timestamp":1792431939789,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jceh.2023.05.016","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T12:20:55Z","timestamp":1685708455000},"page":"1047-1060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Von Willebrand Factor as a Biomarker for Liver Disease \u2013 An Update"],"prefix":"10.1016","volume":"13","author":[{"given":"Anshuman","family":"Elhence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1247-437X","authenticated-orcid":false,"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2023.05.016_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000339426","article-title":"von Willebrand factor: more than a regulator of hemostasis and thrombosis","volume":"128","author":"Luo","year":"2012","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jceh.2023.05.016_bib2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.510230613","article-title":"High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia","volume":"23","author":"Ferro","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.05.016_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0168-8278(02)00199-X","article-title":"Haemostatic abnormalities in patients with liver disease","volume":"37","author":"Lisman","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025656","article-title":"von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis","volume":"9","author":"Zou","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jceh.2023.05.016_bib5","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.25806","article-title":"von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis","volume":"56","author":"Ferlitsch","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.05.016_bib6","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/apt.14522","article-title":"Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity","volume":"47","author":"Mandorfer","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2023.05.016_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149230","article-title":"The VITRO score (von Willebrand factor antigen\/thrombocyte ratio) as a new marker for clinically significant portal hypertension in comparison to other non-invasive parameters of fibrosis including ELF test","volume":"11","author":"Hametner","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2023.05.016_bib8","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.cgh.2021.07.012","article-title":"Decreasing von Willebrand factor levels upon nonselective beta blocker therapy indicate a decreased risk of further decompensation, acute-on-chronic liver failure, and death","volume":"20","author":"Jachs","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1160\/th15-08-0620","article-title":"The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials","volume":"115","author":"Sahebkar","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jceh.2023.05.016_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jceh.2023.05.016_bib11","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in\u00a0vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2023.05.016_bib12","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1074\/jbc.M310436200","article-title":"An experimental model to study the in\u00a0vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation","volume":"279","author":"Lenting","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2023.05.016_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.thromres.2004.07.020","article-title":"Platelet physiology and thrombosis","volume":"114","author":"Andrews","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.jceh.2023.05.016_bib14","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood-2002-05-1550","article-title":"Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension","volume":"101","author":"Shankaran","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2023.05.016_bib15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood-2006-05-022756","article-title":"VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors","volume":"109","author":"Dasgupta","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2023.05.016_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1538-7836.2005.01770.x","article-title":"Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice","volume":"4","author":"Terraube","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jceh.2023.05.016_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mva.2003.63","article-title":"Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies","volume":"37","author":"Qin","year":"2003","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jceh.2023.05.016_bib18","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1182\/blood-2010-03-276311","article-title":"von Willebrand factor promotes leukocyte extravasation","volume":"116","author":"Petri","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2023.05.016_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2023.05.016_bib20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2007.02.006","article-title":"Vascular endothelial dysfunction in cirrhosis","volume":"46","author":"Iwakiri","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0168-8278(95)80424-2","article-title":"Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation","volume":"22","author":"Lin","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1160\/TH03-05-0310","article-title":"Factor VIII expression in liver disease","volume":"91","author":"Hollestelle","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jceh.2023.05.016_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2023.05.016_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ijlh.12345","article-title":"Laboratory diagnosis of von Willebrand disease","volume":"37","author":"Roberts","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jceh.2023.05.016_bib25","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.05.016_bib26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2023.05.016_bib27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/gut.2010.235689","article-title":"Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension","volume":"60","author":"La Mura","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2023.05.016_bib28","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3109\/00365521.2015.1037346","article-title":"von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis","volume":"50","author":"Wu","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.05.016_bib29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jhep.2014.04.025","article-title":"Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis","volume":"61","author":"Horvatits","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib30","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.dld.2022.06.010","article-title":"Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease","volume":"54","author":"Pomej","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2023.05.016_bib31","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2016.06.002","article-title":"von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia","volume":"65","author":"Kalambokis","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hep.31047","article-title":"The von Willebrand factor facilitates model for end-stage liver disease\u2013independent risk stratification on the waiting list for liver transplantation","volume":"72","author":"Gy\u00f6ri","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.05.016_bib33","author":"Tiwari"},{"issue":"1S suppl 1","key":"10.1016\/j.jceh.2023.05.016_bib34","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1097\/MEG.0000000000002056","article-title":"Reticuloendothelial activation correlates with disease severity and predicts mortality in severe alcoholic hepatitis","volume":"33","author":"Vijayalekshmi","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib35","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/MEG.0000000000001491","article-title":"Systematic review: role of elevated plasma von-Willebrand factor as predictor of mortality in patients with chronic liver disease","volume":"31","author":"Eidelberg","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12664-016-0708-2","article-title":"Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure","volume":"35","author":"Prasanna","year":"2016","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.05.016_bib37","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000123","article-title":"Von Willebrand and factor VIII portosystemic circulation gradient in cirrhosis: implications for portal vein thrombosis","volume":"11","author":"Praktiknjo","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jceh.2023.05.016_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3851\/IMP1654","article-title":"von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4","volume":"15","author":"Pramhas","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jceh.2023.05.016_bib39","article-title":"Baveno VII - Renewing consensus in portal hypertension: report of the Baveno VII Consensus Workshop: personalized care in portal hypertension","author":"de Franchis","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib40","series-title":"Portal Hypertension VII","first-page":"135","article-title":"Emerging non-invasive markers: imaging, blood, and liver clearance tests","author":"Palaniyappan","year":"2022"},{"key":"10.1016\/j.jceh.2023.05.016_bib41","first-page":"67","article-title":"Predictive and prognostic value of von Willebrand factor in patients with cirrhosis and esophageal varices","volume":"9","author":"El-Toukhy","year":"2019","journal-title":"Afro-Egypt J Infect Endem Dis"},{"key":"10.1016\/j.jceh.2023.05.016_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s43066-021-00159-8","article-title":"Role of plasma von Willebrand factor antigen in prediction of esophageal varices in pediatric and adolescent patients with portal hypertension","volume":"11","author":"El Shazli","year":"2021","journal-title":"Egypt Liver J"},{"key":"10.1016\/j.jceh.2023.05.016_bib43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4236\/ojgas.2014.44023","article-title":"Predictors of bleeding from esophageal varices: the role of factor VII and von Willebrand factor (vWF)","volume":"4","author":"Ghweil","year":"2014","journal-title":"Open J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.05.016_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MEG.0000000000001272","article-title":"Role of the von Willebrand factor and the VITRO score as predictors for variceal bleeding in patients with hepatitis C-related cirrhosis","volume":"31","author":"Ibrahim","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/apt.12564","article-title":"Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"39","author":"Maieron","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2023.05.016_bib46","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00535-019-01656-9","article-title":"The von Willebrand factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis","volume":"55","author":"Schwarzer","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2023.05.016_bib47","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/hep.26372","article-title":"An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome","volume":"58","author":"Hugenholtz","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.05.016_bib48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12664-019-00989-w","article-title":"Rodenticidal hepatotoxicity: raised plasma Von Willebrand factor levels predict in-hospital survival and preliminary report of the outcome of Von Willebrand factor reducing management protocol","volume":"38","author":"Sardar","year":"2019","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.05.016_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.16198","article-title":"Reticuloendothelial activation and phenotypic alteration of peripheral monocytes with enhanced liver recruitment drive liver injury secondary to yellow phosphorus","author":"Vijayalekshmi","year":"2023","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jhep.2019.09.030","article-title":"Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in mice","volume":"72","author":"Groeneveld","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib51","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/hep.31507","article-title":"VWF\/ADAMTS13 imbalance, but not global coagulation or fibrinolysis, is associated with outcome and bleeding in acute liver failure","volume":"73","author":"Driever","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2023.05.016_bib52","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1177\/2050640618779660","article-title":"von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C","volume":"6","author":"Takaya","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jceh.2023.05.016_bib53","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12876-019-1082-1","article-title":"VWF\/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma","volume":"19","author":"Takaya","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2023.05.016_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221125683","article-title":"What is the role of Von Willebrand factor in chronic hepatitis B virus infection to hepatocellular carcinoma: a review article","volume":"13","author":"Xiang","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jceh.2023.05.016_bib55","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4251\/wjgo.v11.i5.424","article-title":"ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma","volume":"11","author":"Takaya","year":"2019","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.jceh.2023.05.016_bib56","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5009\/gnl17115","article-title":"von Willebrand factor antigen predicts outcomes in patients after liver resection of hepatocellular carcinoma","volume":"14","author":"Schwarz","year":"2020","journal-title":"Gut Liver"},{"key":"10.1016\/j.jceh.2023.05.016_bib57","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s10620-011-1729-4","article-title":"Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency","volume":"56","author":"Mackie","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2023.05.016_bib58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12664-014-0460-4","article-title":"ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertension","volume":"33","author":"Goel","year":"2014","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.05.016_bib59","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12664-017-0786-9","article-title":"ADAMTS13 missense variants associated with defective activity and secretion of ADAMTS13 in a patient with non-cirrhotic portal hypertension","volume":"36","author":"Goel","year":"2017","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2023.05.016_bib60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0049-3848(00)00297-8","article-title":"Inhibitory activity of aspirin on von Willebrand factor-induced platelet aggregation","volume":"99","author":"Homoncik","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.jceh.2023.05.016_bib61","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jth.15312","article-title":"Targeting von Willebrand factor in liver diseases: a novel therapeutic strategy?","volume":"19","author":"Groeneveld","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jceh.2023.05.016_bib62","article-title":"Targeting raised von Willebrand factor levels in liver diseases: opening up newer therapeutic avenues","year":"2020","journal-title":"EMJ Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib63","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jceh.2021.07.010","article-title":"Low volume plasma exchange and low dose steroid improve survival in patients with alcohol-related acute on chronic liver failure and severe alcoholic hepatitis \u2013 preliminary experience","volume":"12","author":"Kumar","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2023.05.016_bib64","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jceh.2022.10.013","article-title":"Improving transplant-free survival with low-volume plasma exchange to treat children with rodenticide induced hepatotoxicity","volume":"13","author":"Thomas","year":"2023","journal-title":"J\u00a0Clin Exp Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323001068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688323001068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:11:19Z","timestamp":1760854279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688323001068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0973688323001068"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2023.05.016","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Von Willebrand Factor as a Biomarker for Liver Disease \u2013 An Update","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2023.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}